Citations (161)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Vo Van Giau, Vorapun Senanarong, Eva Bagyinszky, Chanin Limwongse, Seong Soo A An & SangYun Kim. (2018) Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease. Neuropsychiatric Disease and Treatment 14, pages 3015-3023.
Read now
Read now
Vo Van Giau, Jung-Min Pyun, Eva Bagyinszky, Seong Soo A An & SangYun Kim. (2018) A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease. Clinical Interventions in Aging 13, pages 1321-1329.
Read now
Read now
Kyung Won Park, Seong Soo An, Eva Bagyinszky & SangYun Kim. (2017) A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction. Clinical Interventions in Aging 12, pages 367-375.
Read now
Read now
Seong Soo An, Sun Ah Park, Eva Bagyinszky, Sun Oh Bae, Yoon-Jeong Kim, Ji Young Im, Kyung Won Park, Kee Hyung Park, Eun-Joo Kim, Jee Hyang Jeong, Jong Hun Kim, Hyun Jeong Han, Seong Hye Choi & SangYun Kim. (2016) A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease. Clinical Interventions in Aging 11, pages 1817-1822.
Read now
Read now
Eva Bagyinszky, Young Chul Youn, Seong Soo A An & SangYun Kim. (2016) Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries. Clinical Interventions in Aging 11, pages 1467-1488.
Read now
Read now
Yan Cai, Seong Soo A An & SangYun Kim. (2015) Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders. Clinical Interventions in Aging 10, pages 1163-1172.
Read now
Read now
Eva Bagyinszky, Young Chul Youn, Seong Soo A An & SangYun Kim. (2014) The genetics of Alzheimer’s disease. Clinical Interventions in Aging 9, pages 535-551.
Read now
Read now
Boris Decourt, Aaron Walker, Amanda Gonzales, Michael Malek-Ahmadi, Carolyn Liesback, Kathryn J. Davis, Christine M. Belden, Sandra A. Jacobson & Marwan N. Sabbagh. (2013) Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets 24:3, pages 235-238.
Read now
Read now
Martin Loef & Harald Walach. (2013) The Omega-6/Omega-3 Ratio and Dementia or Cognitive Decline: A Systematic Review on Human Studies and Biological Evidence. Journal of Nutrition in Gerontology and Geriatrics 32:1, pages 1-23.
Read now
Read now
Andrew J. Petersen & David A. Wassarman. (2012) Drosophila innate immune response pathways moonlight in neurodegeneration. Fly 6:3, pages 169-172.
Read now
Read now
Xiaohan Wang, Xiang Gao & Ying Xu. (2011) MAGED1: Molecular insights and clinical implications. Annals of Medicine 43:5, pages 347-355.
Read now
Read now
Siddhartha Mondragón-Rodríguez, Gustavo Basurto-Islas, Hyoung-gon Lee, George Perry, Xiongwei Zhu, Rudy J Castellani & Mark A Smith. (2010) Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis. Expert Review of Neurotherapeutics 10:5, pages 683-691.
Read now
Read now
Bess Frost & Marc I. Diamond. (2009) The expanding realm of prion phenomena in neurodegenerative disease. Prion 3:2, pages 74-77.
Read now
Read now
Articles from other publishers (148)
Stephanie Gastelum, Allison F. Michael & Timothy A. Bolger. (2023)
Saccharomyces cerevisiae
as a research tool for
RNA
‐mediated human disease
. WIREs RNA.
Crossref
Crossref
Jieyi Liu, Yirong Xie, Yao Lu, Zhiqiang Zhao, Zhixiong Zhuang, Linqing Yang, Haiyan Huang, Hongya Li, Zhiyi Mao, Shurong Pi, Fubin Chen & Yun He. (2023) APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer’s Disease in Mice via the Blood-Brain Barrier, Amyloid-β, and Inflammation. Journal of Alzheimer's Disease 94:1, pages 115-136.
Crossref
Crossref
Wang Zhaoxia, Wang Chenyu, Yuan ZhuangZhuang, Fan Liangliang, Lin Xue & Tang Tieyu. (2023) Whole-exome sequencing detected a novel APP variant in a Han-Chinese family with Alzheimer’s disease. Molecular Biology Reports 50:6, pages 5267-5271.
Crossref
Crossref
Xingxin Pan, Zeynep H Coban Akdemir, Ruixuan Gao, Xiaoqian Jiang, Gloria M Sheynkman, Erxi Wu, Jason H Huang, Nidhi Sahni & S Stephen Yi. (2023) AD-Syn-Net: systematic identification of Alzheimer’s disease-associated mutation and co-mutation vulnerabilities via deep learning. Briefings in Bioinformatics 24:2.
Crossref
Crossref
Liling Dong, Caiyan Liu, Longze Sha, Chenhui Mao, Jie Li, Xinying Huang, Jie Wang, Shanshan Chu, Bin Peng, Liying Cui, Qi Xu & Jing Gao. (2022) PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer’s Disease: Data from PUMCH Dementia Cohort. Journal of Alzheimer's Disease 87:4, pages 1549-1556.
Crossref
Crossref
Sercan Kenanoglu, Nefise Kandemir, Hilal Akalin, Nuriye Gokce, Mehmet F. Gol, Murat Gultekin, Emel Koseoglu, Meral Mirza & Munis Dundar. (2022) Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease. Global Medical Genetics 09:02, pages 110-117.
Crossref
Crossref
Marcella Catania, Alessandro Marti, Giacomina Rossi, Anna Fioretti, Chiara Boiocchi, Martina Ricci, Federico Gasparini, Daniela Beltrami, Valeria Crepaldi, Veronica Redaelli, Giorgio Giaccone & Giuseppe Di Fede. (2022) The novel I213S mutation in PSEN1 gene is located in a hotspot codon associated with familial early-onset Alzheimer's disease. Neurobiology of Aging 112, pages 191-196.
Crossref
Crossref
Kyu-Hwan Shim, Min-Ju Kang, Heewon Bae, Danyeong Kim, Jiwon Park, Seong-Soo An & Da-Eun Jeong. (2022) A Possible Pathogenic PSEN2 Gly56Ser Mutation in a Korean Patient with Early-Onset Alzheimer’s Disease. International Journal of Molecular Sciences 23:6, pages 2967.
Crossref
Crossref
Xiaoyu Zhang, Meijaun Zou, Yuwei Wu, Danli Jiang, Ting Wu, Yihan Zhao, Di Wu, Jing Cui & Gang Li. (2022)
Regulation of the Late Onset alzheimer’s Disease Associated
HLA-DQA1/DRB1
Expression
. American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752210850.
Crossref
Crossref
Federica Perrone, Rita Cacace, Julie van der Zee & Christine Van Broeckhoven. (2021) Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases. Genome Medicine 13:1.
Crossref
Crossref
Navatha Shree Sharma, Anik Karan, Donghee Lee, Zheng Yan & Jingwei Xie. (2021) Advances in Modeling Alzheimer's Disease In Vitro. Advanced NanoBiomed Research 1:12.
Crossref
Crossref
Luca Muzio, Alice Viotti & Gianvito Martino. (2021) Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Frontiers in Neuroscience 15.
Crossref
Crossref
D. G. Garbuz, O. G. Zatsepina & M. B. Evgen’ev. (2021) Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis. Molecular Biology 55:5, pages 670-682.
Crossref
Crossref
Gongbu Pan, Anna King, Feitong Wu, Steve Simpson-Yap, Adele Woodhouse, Andrew Phipps & James C. Vickers. (2021) The potential roles of genetic factors in predicting ageing-related cognitive change and Alzheimer’s disease. Ageing Research Reviews 70, pages 101402.
Crossref
Crossref
Julie Hoogmartens, Elisabeth Hens, Sebastiaan Engelborghs, Rik Vandenberghe, Peter-P. De Deyn, Rita Cacace, Christine Van Broeckhoven, P. Cras, J. Goeman, R. Crols, J.L. De Bleecker, T. Van Langenhove, A. Sieben, B. Dermaut, O. Deryck, B. Bergmans & J. Versijpt. (2021) Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer’s disease. Neurobiology of Aging 99, pages 100.e17-100.e23.
Crossref
Crossref
Sally Hunter & Carol Brayne. (2021) Amyloid in the ageing brain: New frameworks and perspectives. Aging Brain 1, pages 100008.
Crossref
Crossref
Ryan Brice, Joshua Kehler & Li Yao. 2021. Methods in iPSC Technology. Methods in iPSC Technology
123
162
.
Federica Perrone, Maria Bjerke, Elisabeth Hens, Anne Sieben, Maarten Timmers, Arne De Roeck, Rik Vandenberghe, Kristel Sleegers, Jean-Jacques Martin, Peter P. De Deyn, Sebastiaan Engelborghs, Julie van der Zee, Christine Van Broeckhoven, Rita Cacace, Johan Goeman, Roeland Crols, Bart Dermaut, Adrian Ivanoiu, Bernard Hanseeuw, Olivier Deryck, Bruno Bergmans, Jan Versijpt, Janssen Pharmaceutica & Takaomi Saido. (2020) Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref
Budheswar Dehury, Arun K. Somavarapu & Kasper P. Kepp. (2020) A computer-simulated mechanism of familial Alzheimer’s disease: Mutations enhance thermal dynamics and favor looser substrate-binding to γ-secretase. Journal of Structural Biology 212:3, pages 107648.
Crossref
Crossref
Md. Tanvir Kabir, Md. Sahab Uddin, Jinnat Ruksana Setu, Ghulam Md Ashraf, May N. Bin-Jumah & Mohamed M. Abdel-Daim. (2020) Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer’s Disease. Neurotoxicity Research 38:4, pages 833-849.
Crossref
Crossref
Sudip Dhakal & Ian Macreadie. (2020) Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease. International Journal of Molecular Sciences 21:21, pages 8014.
Crossref
Crossref
Linda L. Chao. (2020) The Prevalence of Mild Cognitive Impairment in a Convenience Sample of 202 Gulf War Veterans. International Journal of Environmental Research and Public Health 17:19, pages 7158.
Crossref
Crossref
Budheswar Dehury, Ning Tang, Rukmankesh Mehra, Tom L. Blundell & Kasper P. Kepp. (2020) Side-by-side comparison of Notch- and C83 binding to γ-secretase in a complete membrane model at physiological temperature. RSC Advances 10:52, pages 31215-31232.
Crossref
Crossref
Christopher R. Beam, Cody Kaneshiro, Jung Yun Jang, Chandra A. Reynolds, Nancy L. Pedersen & Margaret Gatz. (2020) A Twin Study of Sex Differences in Genetic Risk for All Dementia, Alzheimer’s Disease (AD), and Non-AD Dementia. Journal of Alzheimer's Disease 76:2, pages 539-551.
Crossref
Crossref
Osamu Katayama, Sangyoon Lee, Keitaro Makino, Ippei Chiba, Seongryu Bae, Yohei Shinkai, Kenji Harada & Hiroyuki Shimada. (2020) The Association between Neighborhood Amenities and Cognitive Function: Role of Lifestyle Activities. Journal of Clinical Medicine 9:7, pages 2109.
Crossref
Crossref
Filip Kosel, Jessica M.S. Pelley & Tamara B. Franklin. (2020) Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology. Neuroscience & Biobehavioral Reviews 112, pages 634-647.
Crossref
Crossref
Valeria D’Argenio & Daniela Sarnataro. (2020) New Insights into the Molecular Bases of Familial Alzheimer’s Disease. Journal of Personalized Medicine 10:2, pages 26.
Crossref
Crossref
Annika Höhn, Antonella Tramutola & Roberta Cascella. (2020) Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress. Oxidative Medicine and Cellular Longevity 2020, pages 1-21.
Crossref
Crossref
Tsz Hang Wong, Harro Seelaar, Shamiram Melhem, Annemieke J.M. Rozemuller & John C. van Swieten. (2020) Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations. Neurobiology of Aging 86, pages 201.e9-201.e14.
Crossref
Crossref
David Mengel, Lei Liu, Raina Yamamoto, Stefan Zülow, Cornelius Deuschl, Dirk M. Hermann, Inga Zerr, Dennis J. Selkoe & Richard Dodel. (2020) A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer's disease family. Neurobiology of Aging 85, pages 154.e5-154.e7.
Crossref
Crossref
Zdeněk Fišar, Roman Jirák, Martina Zvěřová, Vladimír Setnička, Lucie Habartová, Jana Hroudová, Zdislava Vaníčková & Jiří Raboch. (2019) Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease. Clinical Biochemistry 72, pages 71-80.
Crossref
Crossref
Maryam Rezazadeh, Hassan Hosseinzadeh, Mohsen Moradi, Behnaz Salek Esfahani, Shahrzad Talebian, Shaho Parvin & Jalal Gharesouran. (2019) Genetic discoveries and advances in late‐onset Alzheimer’s disease. Journal of Cellular Physiology 234:10, pages 16873-16884.
Crossref
Crossref
Vo Van Giau, Eva Bagyinszky, Young Chul Youn, Seong Soo A. An & SangYun Kim. (2019) APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease. International Journal of Molecular Sciences 20:19, pages 4757.
Crossref
Crossref
Eva Vico Varela, Guillaume Etter & Sylvain Williams. (2019) Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance. Neurobiology of Disease 127, pages 605-615.
Crossref
Crossref
Vo Van Giau, Eva Bagyinszky, Young Soon Yang, Young Chul Youn, Seong Soo A. An & Sang Yun Kim. (2019) Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing. Scientific Reports 9:1.
Crossref
Crossref
Miguel Maia & Emília Sousa. (2019) BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease. Pharmaceuticals 12:1, pages 41.
Crossref
Crossref
Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi, Eider Arenaza‐Urquijo, Arlene J. Astell, Claudio Babiloni, Alex Bahar‐Fuchs, Joanne Bell, Gene L. Bowman, Adam M. Brickman, Gaël Chételat, Carrie Ciro, Ann D. Cohen, Peggye Dilworth‐Anderson, Hiroko H. Dodge, Simone Dreux, Steven Edland, Anna Esbensen, Lisbeth Evered, Michael Ewers, Keith N. Fargo, Juan Fortea, Hector Gonzalez, Deborah R. Gustafson, Elizabeth Head, James A. Hendrix, Scott M. Hofer, Leigh A. Johnson, Roos Jutten, Kerry Kilborn, Krista L. Lanctôt, Jennifer J. Manly, Ralph N. Martins, Michelle M. Mielke, Martha Clare Morris, Melissa E. Murray, Esther S. Oh, Mario A. Parra, Robert A. Rissman, Catherine M. Roe, Octavio A. Santos, Nikolaos Scarmeas, Lon S. Schneider, Nicole Schupf, Sietske Sikkes, Heather M. Snyder, Hamid R. Sohrabi, Yaakov Stern, Andre Strydom, Yi Tang, Graciela Muniz Terrera, Charlotte Teunissen, Debora Melo van Lent, Michael Weinborn, Linda Wesselman, Donna M. Wilcock, Henrik Zetterberg & Sid E. O'Bryant. (2018) Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia 15:2, pages 292-312.
Crossref
Crossref
Fadia El Bitar, Najeeb Qadi, Saad Al Rajeh, Amna Majrashi, Sara Abdulaziz, Nada Majrashi, Maznah Al Inizi, Asma Taher & Nada Al Tassan. (2019) Genetic Study of Alzheimer’s Disease in Saudi Population. Journal of Alzheimer's Disease 67:1, pages 231-242.
Crossref
Crossref
Hlin Kvartsberg, Tammaryn Lashley, Christina E. Murray, Gunnar Brinkmalm, Nicholas C. Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow & Erik Portelius. (2018) The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease. Acta Neuropathologica 137:1, pages 89-102.
Crossref
Crossref
Matea Nikolac Perkovic & Nela Pivac. 2019. Frontiers in Psychiatry. Frontiers in Psychiatry
27
52
.
Haowei Jiang, Suman Jayadev, Michael Lardelli & Morgan Newman. (2018) A Review of the Familial Alzheimer’s Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1. Journal of Alzheimer's Disease 66:4, pages 1323-1339.
Crossref
Crossref
Cindy K. Barha & Teresa Liu-Ambrose. (2018) Exercise and the Aging Brain: Considerations for Sex Differences. Brain Plasticity 4:1, pages 53-63.
Crossref
Crossref
Ning Tang & Kasper P. Kepp. (2018) Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer’s Disease. Journal of Alzheimer's Disease 66:3, pages 939-945.
Crossref
Crossref
Federica Perrone, Rita Cacace, Sara Van Mossevelde, Tobi Van den Bossche, Peter P. De Deyn, Patrick Cras, Sebastiaan Engelborghs, Julie van der Zee & Christine Van Broeckhoven. (2018) Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis. Neurobiology of Aging 69, pages 292.e7-292.e14.
Crossref
Crossref
Cindy K Barha & Teresa Liu-Ambrose. (2018) Exercise and the Aging Brain: Considerations for Sex Differences. Brain Plasticity, pages 1-11.
Crossref
Crossref
Frank J. Wolters, Hieab H.H. Adams, Daniel Bos, Silvan Licher & M. Arfan Ikram. (2018) Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers. Journal of Alzheimer's Disease 64:s1, pages S145-S159.
Crossref
Crossref
Meng-Hui Dai, Hui Zheng, Ling-Dan Zeng & Yan Zhang. (2017) The genes associated with early-onset Alzheimer’s disease. Oncotarget 9:19, pages 15132-15143.
Crossref
Crossref
JessicaM Hogestyn, DavidJ Mock & Margot Mayer-Proschel. (2018) Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regeneration Research 13:2, pages 211.
Crossref
Crossref
Rong Cheng, Min Tang, Izri Martinez, Temitope Ayodele, Penelope Baez, Dolly Reyes‐Dumeyer, Rafael Lantigua, Martin Medrano, Ivonne Jimenez‐Velazquez, Joseph H. Lee, Gary W. Beecham & Christiane Reitz. (2018) Linkage analysis of multiplex Caribbean Hispanic families loaded for unexplained early‐onset cases identifies novel Alzheimer's disease loci. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10:1, pages 554-562.
Crossref
Crossref
Jancy Nixon Abraham & Corinne Nardin. (2018) Interaction of polymers with amyloidogenic peptides. Polymer International 67:1, pages 15-24.
Crossref
Crossref
Min Tang & Christiane Reitz. (2017) Genetics of Alzheimer's disease: an update. Future Neurology 12:4, pages 237-247.
Crossref
Crossref
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, Sergi G Costafreda, Jonathan Huntley, David Ames, Clive Ballard, Sube Banerjee, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper, Nick Fox, Laura N Gitlin, Robert Howard, Helen C Kales, Eric B Larson, Karen Ritchie, Kenneth Rockwood, Elizabeth L Sampson, Quincy Samus, Lon S Schneider, Geir Selbæk, Linda Teri & Naaheed Mukadam. (2017) Dementia prevention, intervention, and care. The Lancet 390:10113, pages 2673-2734.
Crossref
Crossref
Kasper P. Kepp. (2017) Alzheimer’s disease: How metal ions define β-amyloid function. Coordination Chemistry Reviews 351, pages 127-159.
Crossref
Crossref
H?l?ne-Marie Lanoisel?e, Ga?l Nicolas, David Wallon, Anne Rovelet-Lecrux, Morgane Lacour, St?phane Rousseau, Anne-Claire Richard, Florence Pasquier, Adeline Rollin-Sillaire, Olivier Martinaud, Muriel Quillard-Muraine, Vincent de la Sayette, Claire Boutoleau-Bretonniere, Fr?d?rique Etcharry-Bouyx, Val?rie Chauvir?Marie Sarazin, Isabelle le Ber, St?phane Epelbaum, Th?r?se Jonveaux, Olivier Rouaud, Mathieu Ceccaldi, Olivier F?lician, Olivier Godefroy, Maite Formaglio, Bernard Croisile, Sophie Auriacombe, Ludivine Chamard, Jean-Louis Vincent, Mathilde Sauv?e, Cecilia Marelli-Tosi, Audrey Gabelle, Canan Ozsancak, J?r?mie Pariente, Claire Paquet, Didier Hannequin & Dominique Campion. (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLOS Medicine 14:3, pages e1002270.
Crossref
Crossref
Apostolia Fragkouli, Pelagia Koukouraki, Ioannis S. Vlachos, Maria D. Paraskevopoulou, Artemis G. Hatzigeorgiou & Epaminondas Doxakis. (2017) Neuronal ELAVL proteins utilize AUF-1 as a co-partner to induce neuron-specific alternative splicing of APP. Scientific Reports 7:1.
Crossref
Crossref
Markus J. Schwarz. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
631
670
.
Pritika Narayan & Mike Dragunow. 2017. Neuroepigenomics in Aging and Disease. Neuroepigenomics in Aging and Disease
321
336
.
Yan Cai, Eva Bagyinszky, Seong Soo A. An & Sang Yun Kim. (2017) In silico modeling of pathogenic or possibly pathogenic point mutations in PSEN2. Molecular & Cellular Toxicology 12:4, pages 453-464.
Crossref
Crossref
Jianhua Su, Shihong Wen, Jinlong Zhu, Ruiping Liu & Jinsong Yang. (2016) Meta-analysis of cyclooxygenase-2 (COX-2) 765G>C polymorphism and Alzheimer?s disease. Journal of Clinical Neuroscience 31, pages 4-9.
Crossref
Crossref
Kasper P. Kepp. (2016) Alzheimer’s disease due to loss of function: A new synthesis of the available data. Progress in Neurobiology 143, pages 36-60.
Crossref
Crossref
Jan Verheijen, Tobi Van den Bossche, Julie van der Zee, Sebastiaan Engelborghs, Raquel Sanchez-Valle, Albert Lladó, Caroline Graff, Håkan Thonberg, Pau Pastor, Sara Ortega-Cubero, Maria A. Pastor, Luisa Benussi, Roberta Ghidoni, Giuliano Binetti, Jordi Clarimon, Alberto Lleó, Juan Fortea, Alexandre de Mendonça, Madalena Martins, Oriol Grau-Rivera, Ellen Gelpi, Karolien Bettens, Ligia Mateiu, Lubina Dillen, Patrick Cras, Peter P. De Deyn, Christine Van Broeckhoven & Kristel Sleegers. (2016) A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease. Acta Neuropathologica 132:2, pages 213-224.
Crossref
Crossref
Luise Christine Löwe, Christian Gaser & Katja Franke. (2016) The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease. PLOS ONE 11:7, pages e0157514.
Crossref
Crossref
Elise Cuyvers & Kristel Sleegers. (2016) Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond. The Lancet Neurology 15:8, pages 857-868.
Crossref
Crossref
Rita Cacace, Kristel Sleegers & Christine Van Broeckhoven. (2016) Molecular genetics of early‐onset Alzheimer's disease revisited. Alzheimer's & Dementia 12:6, pages 733-748.
Crossref
Crossref
Laura Cervera-Carles & Jordi Clarimón. (2016) Genetic and Epigenetic Architecture of Alzheimer’s Dementia. Current Genetic Medicine Reports 4:1, pages 7-15.
Crossref
Crossref
Markus J. Schwarz. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
41
.
Lars Lannfelt. 2016. Immunotherapy and Biomarkers in Neurodegenerative Disorders. Immunotherapy and Biomarkers in Neurodegenerative Disorders
51
60
.
Arun Kumar Somavarapu & Kasper P. Kepp. (2015) Direct Correlation of Cell Toxicity to Conformational Ensembles of Genetic Aβ Variants. ACS Chemical Neuroscience 6:12, pages 1990-1996.
Crossref
Crossref
O. G. Tatarnikova, M. A. Orlov & N. V. Bobkova. (2016) Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties. Biochemistry (Moscow) 80:13, pages 1800-1819.
Crossref
Crossref
Lin Tan, Jin-Tai Yu & Lan Tan. (2014) Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases. Molecular Neurobiology 51:3, pages 1249-1262.
Crossref
Crossref
Eri Kawai, Nobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, Kenji Tgai, Tohru Ohnuma, Hiromi Shimazaki, Aiko Toda, Koji Kasanuki, Toshiki Takayama, Ayako Suzuki, Kazuhiko Nakayama, Hisashi Yamada & Heii Arai. (2015) Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population. NeuroMolecular Medicine 17:2, pages 170-177.
Crossref
Crossref
I. А. Zhuravin, N. N. Nalivaeva, D. I. Kozlova, E. G. Kochkina, Ya. B. Fedorova & S. I. Gavrilova. (2015) The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:12, pages 110.
Crossref
Crossref
Isabel Morgado & Megan Garvey. 2015. Lipids in Protein Misfolding. Lipids in Protein Misfolding
67
94
.
Jone Garai, Robert B. Uddo, Maura C. Mohler, Nicole Pelligrino, Richard Scribner, Melinda S. Sothern & Jovanny Zabaleta. 2015. Cancer Epigenetics. Cancer Epigenetics
689
707
.
Christian Darabos, Marquitta J White, Britney E Graham, Derek N Leung, Scott M Williams & Jason H Moore. (2014) The multiscale backbone of the human phenotype network based on biological pathways. BioData Mining 7:1.
Crossref
Crossref
Zeynep Sezgin & Yildiz Dincer. (2014) Alzheimer's disease and epigenetic diet. Neurochemistry International 78, pages 105-116.
Crossref
Crossref
S Li, J Deng, H Hou, J Tian, B Giunta, Y Wang, D Sawmiller, A Smith, P R Sanberg, D Obregon, T Mori & J Tan. (2014) Specific antibody binding to the APP672–699 region shifts APP processing from α- to β-cleavage. Cell Death & Disease 5:8, pages e1374-e1374.
Crossref
Crossref
Andras Bilkei-Gorzo. (2014) Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacology & Therapeutics 142:2, pages 244-257.
Crossref
Crossref
K. Gapp, B.T. Woldemichael, J. Bohacek & I.M. Mansuy. (2014) Epigenetic regulation in neurodevelopment and neurodegenerative diseases. Neuroscience 264, pages 99-111.
Crossref
Crossref
Yao-Wen Liu, Yong-Han He, Yun-Xia Zhang, Wang-Wei Cai, Li-Qin Yang, Liang-You Xu & Qing-Peng Kong. (2014) Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals. Neurobiology of Aging 35:4, pages 935.e11-935.e12.
Crossref
Crossref
Lars Lannfelt, Christer M?ller, Hans Basun, Gunilla Osswald, Dag Sehlin, Andrew Satlin, Veronika Logovinsky & P?r Gellerfors. (2014) Perspectives on future Alzheimer therapies: amyloid-? protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer?s disease. Alzheimer's Research & Therapy 6:2, pages 16.
Crossref
Crossref
Boris Decourt, MiMi Macias, Marwan Sabbagh & Abdu Adem. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease
518
546
.
Meredith N. Braskie, Luis D. Medina, Yaneth Rodriguez-Agudelo, Daniel H. Geschwind, Miguel Angel Macias-Islas, Paul M. Thompson, Jeffrey L. Cummings, Susan Y. Bookheimer & John M. Ringman. (2013) Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease. Human Brain Mapping 34:12, pages 3308-3319.
Crossref
Crossref
Iftach Dolev, Hilla Fogel, Hila Milshtein, Yevgeny Berdichevsky, Noa Lipstein, Nils Brose, Neta Gazit & Inna Slutsky. (2013) Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change. Nature Neuroscience 16:5, pages 587-595.
Crossref
Crossref
Martin A. Kohli, Krista John-Williams, Ruchita Rajbhandary, Adam Naj, Patrice Whitehead, Kara Hamilton, Regina M. Carney, Clinton Wright, Elizabeth Crocco, Harry E. Gwirtzman, Rosalyn Lang, Gary Beecham, Eden R. Martin, John Gilbert, Michael Benatar, Gary W. Small, Deborah Mash, Goldie Byrd, Jonathan L. Haines, Margaret A. Pericak-Vance & Stephan Züchner. (2013) Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians. Neurobiology of Aging 34:5, pages 1519.e5-1519.e12.
Crossref
Crossref
Wenlu Tang, Meixia He, Bo Yang, Kankan Wei, Ming Yin & Lirong Zhang. (2012) Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer?s disease risk in Chinese. Neurological Sciences 34:5, pages 695-699.
Crossref
Crossref
Emma De Feo, Benedetto Simone, Roberto Persiani, Ferdinando Cananzi, Alberto Biondi, Dario Arzani, Rosarita Amore, Domenico D’Ugo, Gualtiero Ricciardi & Stefania Boccia. (2012) A case–control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression. BMC Cancer 12:1.
Crossref
Crossref
Nathalie C. Schnetz‐Boutaud, Joshua Hoffman, Jared E. Coe, Deborah G. Murdock, Margaret A. Pericak‐Vance & Jonathan L. Haines. (2012)
Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated
PICALM
Gene
. Annals of Human Genetics 76:6, pages 448-453.
Crossref
Crossref
Jill S. Goldman. (2012) New Approaches to Genetic Counseling and Testing for Alzheimer?s Disease and Frontotemporal Degeneration. Current Neurology and Neuroscience Reports 12:5, pages 502-510.
Crossref
Crossref
Marc Cruts, Jessie Theuns & Christine Van Broeckhoven. (2012) Locus‐specific mutation databases for neurodegenerative brain diseases. Human Mutation 33:9, pages 1340-1344.
Crossref
Crossref
Ebba Lohmann, Rita J. Guerreiro, Nihan Erginel-Unaltuna, Nicole Gurunlian, Basar Bilgic, Hakan Gurvit, Hasmet A. Hanagasi, Nga Luu, Murat Emre & Andrew Singleton. (2012) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiology of Aging 33:8, pages 1850.e17-1850.e27.
Crossref
Crossref
Iain Rogers, Fiona Kerr, Pedro Martinez, John Hardy, Simon Lovestone & Linda Partridge. (2012) Ageing Increases Vulnerability to A?42 Toxicity in Drosophila. PLoS ONE 7:7, pages e40569.
Crossref
Crossref
Alessandra Pontillo, Eulalia Catamo, Beatrice Arosio, Daniela Mari & Sergio Crovella. (2012) NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease. Alzheimer Disease & Associated Disorders 26:3, pages 277-281.
Crossref
Crossref
Markus Donix, Linda M. Ercoli, Prabha Siddarth, Jesse A. Brown, Laurel Martin-Harris, Alison C. Burggren, Karen J. Miller, Gary W. Small & Susan Y. Bookheimer. (2012) Influence of Alzheimer Disease Family History and Genetic Risk on Cognitive Performance in Healthy Middle-Aged and Older People. The American Journal of Geriatric Psychiatry 20:7, pages 565-573.
Crossref
Crossref
Chunhai Chen, Zhou Zhou, Maoquan Li, Mingyue Qu, Qinlong Ma, Min Zhong, Yanwen Zhang & Zhengping Yu. (2012) Presenilin-2 polymorphisms and risk of sporadic AD: Evidence from a meta-analysis. Gene 503:2, pages 194-199.
Crossref
Crossref
Kangning Liu, Minhua Zhang & Guhan Nagappan. 2012. Alzheimer's Disease. Alzheimer's Disease
163
210
.
Suk Ling Ma, Nelson Leung Sang Tang, Cindy Woon Chi Tam, Victor Wing Cheong Lui, Linda Chiu Wa Lam, Helen Fung Kum Chiu, Jane Ann Driver, Lucia Pastorino & Kun Ping Lu. (2012) A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. Neurobiology of Aging 33:4, pages 804-813.
Crossref
Crossref
Jerome Sarris, Chee Hong Ng & Isaac Schweitzer. (2011) ‘Omic’ Genetic Technologies for Herbal Medicines in Psychiatry. Phytotherapy Research 26:4, pages 522-527.
Crossref
Crossref
Indra Neil Sarkar. (2012) A vector space model approach to identify genetically related diseases. Journal of the American Medical Informatics Association 19:2, pages 249-254.
Crossref
Crossref
Bram Meeus, Aline Verstraeten, David Crosiers, Sebastiaan Engelborghs, Marleen Van den Broeck, Maria Mattheijssens, Karin Peeters, Ellen Corsmit, Ellen Elinck, Barbara Pickut, Rik Vandenberghe, Patrick Cras, Peter Paul De Deyn, Christine Van Broeckhoven & Jessie Theuns. (2012) DLB and PDD: a role for mutations in dementia and Parkinson disease genes?. Neurobiology of Aging 33:3, pages 629.e5-629.e18.
Crossref
Crossref
Abdenour Belkacemi & Charles Ramassamy. (2012) Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade. Free Radical Biology and Medicine 52:3, pages 593-600.
Crossref
Crossref
Martin Loef & Harald Walach. (2011) Copper and iron in Alzheimer's disease: a systematic review and its dietary implications. British Journal of Nutrition 107:1, pages 7-19.
Crossref
Crossref
Hansen Wang & Laurie C. Doering. (2012) Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders. Neural Plasticity 2012, pages 1-15.
Crossref
Crossref
Natalia S. de Groot, Virginia Castillo, Ricardo Graña-Montes & Salvador Ventura. 2012. Computational Drug Discovery and Design. Computational Drug Discovery and Design
199
220
.
Samir Benosman, Xiangjun Meng, Yannick Von Grabowiecki, Lavinia Palamiuc, Lucian Hritcu, Isabelle Gross, Georg Mellitzer, Yoichi Taya, Jean-Philippe Loeffler & Christian Gaiddon. (2011) Complex Regulation of p73 Isoforms after Alteration of Amyloid Precursor Polypeptide (APP) Function and DNA Damage in Neurons. Journal of Biological Chemistry 286:50, pages 43013-43025.
Crossref
Crossref
Thomas L. Kukar, Thomas B. Ladd, Paul Robertson, Sean A. Pintchovski, Brenda Moore, Maralyssa A. Bann, Zhao Ren, Karen Jansen-West, Kim Malphrus, Simone Eggert, Hiroko Maruyama, Barbara A. Cottrell, Pritam Das, Guriqbal S. Basi, Edward H. Koo & Todd E. Golde. (2011) Lysine 624 of the Amyloid Precursor Protein (APP) Is a Critical Determinant of Amyloid β Peptide Length. Journal of Biological Chemistry 286:46, pages 39804-39812.
Crossref
Crossref
Meng Hua Tao, Jian Wei Liu, Michael J. LaMonte, Jing Liu, Lei Wang, Yao He, Xiao Ying Li, Lu Ning Wang & Ling Ye. (2011) Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population. Metabolism 60:10, pages 1488-1496.
Crossref
Crossref
J‐M. Burgunder, J. Finsterer, Z. Szolnoki, B. Fontaine, J. Baets, C. Van Broeckhoven, S. Di Donato, P. De Jonghe, T. Lynch, C. Mariotti, L. Schöls, A. Spinazzola, S. J. Tabrizi, C. Tallaksen, M. Zeviani, H. F. Harbo & T. Gasser. 2011. European Handbook of Neurological Management. European Handbook of Neurological Management
87
96
.
A.V. Maltsev, S. Bystryak & O.V. Galzitskaya. (2011) The role of β-amyloid peptide in neurodegenerative diseases. Ageing Research Reviews 10:4, pages 440-452.
Crossref
Crossref
IL Han Choo, Dong Young Lee, Jee Wook Kim, Eun Hyun Seo, Dong Soo Lee, Yu Kyeong Kim, Shin Gyeom Kim, Shin Young Park, Jong Inn Woo & Eun Jin Yoon. (2011) Relationship of Amyloid-Beta Burden With Age-At-Onset in Alzheimer Disease. The American Journal of Geriatric Psychiatry 19:7, pages 627-634.
Crossref
Crossref
Jian Hu, Yi Xue, Sangwon Lee & Ya Ha. (2011) The crystal structure of GXGD membrane protease FlaK. Nature 475:7357, pages 528-531.
Crossref
Crossref
Nicolas Dupré. (2014) Genetic Susceptibility of Alzheimer's Disease in East Asia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 38:3, pages 394-395.
Crossref
Crossref
Lujia Zhou, Nathalie Brouwers, Iryna Benilova, Annelies Vandersteen, Marc Mercken, Koen Van Laere, Philip Van Damme, David Demedts, Fred Van Leuven, Kristel Sleegers, Kerensa Broersen, Christine Van Broeckhoven, Rik Vandenberghe & Bart De Strooper. (2011) Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation. EMBO Molecular Medicine 3:5, pages 291-302.
Crossref
Crossref
Claudia Padilla & Richard S. Isaacson. (2011) Genetics of Dementia. CONTINUUM: Lifelong Learning in Neurology 17, pages 326-342.
Crossref
Crossref
Ana Miar, Victoria Álvarez, Ana I. Corao, Belén Alonso, Marta Díaz, Manuel Menéndez, Carmen Martínez, Maite Calatayud, Germán Morís & Eliecer Coto. (2011) Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease. Brain Research 1383, pages 252-256.
Crossref
Crossref
Kasia Gustaw Rothenberg, Sandra L Siedlak, Hyoung-gon Lee, Xiongwei Zhu, George Perry & Mark A Smith. (2011) Neurodegenerative processes in Alzheimer’s disease: an overview of pathogenesis with strategic biomarker potential. Future Neurology 6:2, pages 173-185.
Crossref
Crossref
Greg T. Sutherland, Michal Janitz & Jillian J. Kril. (2011) Understanding the pathogenesis of Alzheimer’s disease: will RNA-Seq realize the promise of transcriptomics?. Journal of Neurochemistry 116:6, pages 937-946.
Crossref
Crossref
Steven T. DeKosky, Maria C. Carrillo, Creighton Phelps, David Knopman, Ronald C. Petersen, Richard Frank, Dale Schenk, Donna Masterman, Eric R. Siemers, Jesse M. Cedarbaum, Michael Gold, David S. Miller, Bruce H. Morimoto, Ara S. Khachaturian & Richard C. Mohs. (2011) Revision of the criteria for Alzheimer's disease: A symposium. Alzheimer's & Dementia 7:1.
Crossref
Crossref
Jack H. Jhamandas, Zongming Li, David Westaway, Jing Yang, Simran Jassar & David MacTavish. (2011) Actions of β-Amyloid Protein on Human Neurons Are Expressed through the Amylin Receptor. The American Journal of Pathology 178:1, pages 140-149.
Crossref
Crossref
Brandon K. Harvey, Christopher T. Richie, Barry J. Hoffer & Mikko Airavaara. (2010) Transgenic animal models of neurodegeneration based on human genetic studies. Journal of Neural Transmission 118:1, pages 27-45.
Crossref
Crossref
B. Bondy & M. J. Schwarz. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
599
620
.
Emma De Feo, Jessica Rowell, Gabriella Cadoni, Nicola Nicolotti, Dario Arzani, Arianna Giorgio, Rosarita Amore, Gaetano Paludetti, Gualtiero Ricciardi & Stefania Boccia. (2010) A Case-Control Study on the Effect of Apoliprotein E Genotype on Head and Neck Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 19:11, pages 2839-2846.
Crossref
Crossref
Nils Erik Gilhus, Michael P. Barnes & Michael BraininJ. Hort, J. T. O'Brien, G. Gainotti, T. Pirttila, B. O. Popescu, I. Rektorova, S. Sorbi & P. Scheltens. 2010. European Handbook of Neurological Management. European Handbook of Neurological Management
269
282
.
J. Hort, J. T. O’Brien, G. Gainotti, T. Pirttila, B. O. Popescu, I. Rektorova, S. Sorbi & P. Scheltens. (2010) EFNS guidelines for the diagnosis and management of Alzheimer’s disease. European Journal of Neurology 17:10, pages 1236-1248.
Crossref
Crossref
J L Holtzman. (2010) Are We Prepared to Deal With the Alzheimer's Disease Pandemic?. Clinical Pharmacology & Therapeutics 88:4, pages 563-565.
Crossref
Crossref
Huda Y. Zoghbi & Stephen T. Warren. (2010) Neurogenetics: Advancing the “Next-Generation” of Brain Research. Neuron 68:2, pages 165-173.
Crossref
Crossref
Markus Donix, Alison C. Burggren, Nanthia A. Suthana, Prabha Siddarth, Arne D. Ekstrom, Allison K. Krupa, Michael Jones, Anup Rao, Laurel Martin-Harris, Linda M. Ercoli, Karen J. Miller, Gary W. Small & Susan Y. Bookheimer. (2010) Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. NeuroImage 53:1, pages 37-43.
Crossref
Crossref
Thomas Wisniewski & Einar M. Sigurdsson. (2010) Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1802:10, pages 847-859.
Crossref
Crossref
Terri L. Petkau, S.J. Neal, P.C. Orban, J.L. MacDonald, A.M. Hill, G. Lu, H.H. Feldman, I.R.A. Mackenzie & B.R. Leavitt. (2010) Progranulin expression in the developing and adult murine brain. The Journal of Comparative Neurology 518:19, pages 3931-3947.
Crossref
Crossref
Sophie Raby. (2010) The Medical butterfly effect; how a discovery in a rare disease can have large effects elsewhere.. Cambridge Medicine Journal:9.
Crossref
Crossref
Erik Portelius, Nenad Bogdanovic, Mikael K. Gustavsson, Inga Volkmann, Gunnar Brinkmalm, Henrik Zetterberg, Bengt Winblad & Kaj Blennow. (2010) Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease. Acta Neuropathologica 120:2, pages 185-193.
Crossref
Crossref
Sonia Gandhi & Nicholas W Wood. (2010) Genome-wide association studies: the key to unlocking neurodegeneration?. Nature Neuroscience 13:7, pages 789-794.
Crossref
Crossref
Karen H. Ashe & Kathleen R. Zahs. (2010) Probing the Biology of Alzheimer's Disease in Mice. Neuron 66:5, pages 631-645.
Crossref
Crossref
Jacqueline A Vernarelli, J Scott Roberts, Susan Hiraki, Clara A Chen, L Adrienne Cupples & Robert C Green. (2010) Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. The American Journal of Clinical Nutrition 91:5, pages 1402-1407.
Crossref
Crossref
J‐M. Burgunder, J. Finsterer, Z. Szolnoki, B. Fontaine, J. Baets, C. Van Broeckhoven, S. Di Donato, P. De Jonghe, T. Lynch, C. Mariotti, L. Schöls, A. Spinazzola, S. J. Tabrizi, C. Tallaksen, M. Zeviani, H. F. Harbo & T. Gasser. (2010) EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. European Journal of Neurology 17:5, pages 641-648.
Crossref
Crossref
Rachel Butler, B. Lynn Beattie, Umamon Puang Thong, Emily Dwosh, Colleen Guimond, Howard H. Feldman, Ging-Yuek Robin Hsiung, Ekaterina Rogaeva, Peter St. George-Hyslop & A. Dessa Sadovnick. (2014) A Novel PS1 Gene Mutation in a Large Aboriginal Kindred. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37:3, pages 359-364.
Crossref
Crossref
. (2014) Familial Alzheimer Disease in Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37:3, pages 302-303.
Crossref
Crossref
Brandy R. Matthews. (2010) ALZHEIMER DISEASE UPDATE. CONTINUUM: Lifelong Learning in Neurology 16, pages 15-30.
Crossref
Crossref
Thomas Wisniewski & Allal Boutajangout. (2009) Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models. Brain Structure and Function 214:2-3, pages 201-218.
Crossref
Crossref
Katarzyna Gustaw-Rothenberg, Alan Lerner, David J BondaHyoung-gon LeeXiongwei ZhuGeorge Perry & Mark A Smith. (2010) Biomarkers in Alzheimer’s disease: past, present and future. Biomarkers in Medicine 4:1, pages 15-26.
Crossref
Crossref
Kristel Sleegers, Jean-Charles Lambert, Lars Bertram, Marc Cruts, Philippe Amouyel & Christine Van Broeckhoven. (2010) The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends in Genetics 26:2, pages 84-93.
Crossref
Crossref
A. Rostagno, J. L. Holton, T. Lashley, T. Revesz & Jorge Ghiso. (2009) Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. Cellular and Molecular Life Sciences 67:4, pages 581-600.
Crossref
Crossref
Samer O. Abdul-Hay, Praneeth Edirisinghe & Gregory R. J. Thatcher. (2009) Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels. Journal of Neurochemistry 111:3, pages 683-695.
Crossref
Crossref
Amy Chan, Flaubert Tchantchou, Eugene J. Rogers & Thomas B. Shea. (2009)
Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by
S
-adenosyl methionine
. Journal of Neurochemistry 110:3, pages 831-836.
Crossref
Crossref
Alessandra Giorgi, Laura Di Francesco, Serena Principe, Giuseppina Mignogna, Lau Sennels, Carmine Mancone, Tonino Alonzi, Marco Sbriccoli, Angela De Pascalis, Juri Rappsilber, Franco Cardone, Maurizio Pocchiari, Bruno Maras & M. Eugenia Schininà. (2009) Proteomic profiling of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie. PROTEOMICS 9:15, pages 3802-3814.
Crossref
Crossref
You-Jun Fu, Shuling Xiong, Mark A. Lovell & Bert C. Lynn. (2009) Quantitative Proteomic Analysis of Mitochondria in Aging PS-1 Transgenic Mice. Cellular and Molecular Neurobiology 29:5, pages 649-664.
Crossref
Crossref
Yehezkel Ben-Ari. (2008) Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders. Trends in Neurosciences 31:12, pages 626-636.
Crossref
Crossref
Julie van der ZeeKristel SleegersChristine Van Broeckhoven. (2008) Invited Article: The Alzheimer disease–frontotemporal lobar degeneration spectrum. Neurology 71:15, pages 1191-1197.
Crossref
Crossref